NCT06071416

Brief Summary

A lack of bone in the posterior maxilla, mainly resulting from the combination of alveolar bone resorption after tooth loss, pneumatization of the maxillary sinus, and periodontal disease, leads to increased difficulty during dental implant treatment. The classic technique for maxillary sinus floor augmentation entails the preparation of the trap door to elevate the schneiderian membrane in the lateral sinus wall. it can be done either in a single stage with simultaneous implant placement or in two stages with delayed implant placement, depending on the available residual alveolar ridge height that necessary for implant primary stability. The new compartment created between the floor of maxillary sinus and the elevated membrane was filled with either autogenous, allografts, xenograft or combination of them to maintain space for new bone formation. The disadvantages of such methods are high costs for grafting material, time consuming and high morbidity, because harvesting of bone grafts is needed.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
18

participants targeted

Target at P25-P50 for phase_1

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_1

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 6, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

February 15, 2024

Completed
29 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2024

Completed
17 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2024

Completed
Last Updated

January 31, 2024

Status Verified

January 1, 2024

Enrollment Period

29 days

First QC Date

October 1, 2023

Last Update Submit

January 29, 2024

Conditions

Keywords

sinus floor augmentationbiphasic calcium phosphatePRF

Outcome Measures

Primary Outcomes (1)

  • Vertical bone gain BG

    Vertical bone gain (BG) 6 months after sinus augmentation in both height and density aspects by cone beam CT

    6 months

Study Arms (2)

Group 1 BCP alone

ACTIVE COMPARATOR

Lateral bone augmentation with biphasic calcium phosphate BCP bone substitute application

Procedure: Lateral sinus floor augmentationDrug: Biphasic Calcium Phosphate

Group 2 BCP with I-PRF

ACTIVE COMPARATOR

Lateral bone augmentation with biphasic calcium phosphate BCP bone substitute application with addition of injectable platlet rich fibrin I-PRF

Procedure: Lateral sinus floor augmentationDrug: Biphasic Calcium PhosphateProcedure: Injectable platlets rich fibrin

Interventions

maxillary sinus floor augmentation by lateral approach

Group 1 BCP aloneGroup 2 BCP with I-PRF

appliaction of BCP bone substitute

Group 1 BCP aloneGroup 2 BCP with I-PRF

centrifuge 10 ml of patient blood to get I-PRF that applied to the bone substitute

Group 2 BCP with I-PRF

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Residual bone crest height \< 5 mm and width≥6 mm in the planned implant site.
  • Healed bone crest (at least 6 months elapsed from tooth loss/extraction);

You may not qualify if:

  • Absolute medical contraindications to implant surgery such as uncontrolled diabetes mellitus, blood platelet disorders, serious osseous disorders, and cardiac arrhythmia; history of bone grafting in the posterior maxilla, immunocompromised patients, taking corticosteroids, taking aspirin before the procedure, positive history of chemotherapy and radiotherapy, and maxillary sinus pathologies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

hydroxyapatite-beta tricalcium phosphate

Central Study Contacts

Alzahraa Alghriany, Lecturer

CONTACT

Ahmed Mortada Fikry, Associate professor

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
using automated sequence generation ( randomizer. org) patients will be divided into the two groups ,In sequentially numbered , opaque, sealed envelopes, participants will be enrolled and evaluated while the allocation sequence will be kept a secret from the researchers.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Group I, patients undergo sinus lifting using bone substitute BCP alone. -Group II, patients who undergo sinus lifting using BCP with I-PRF.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer, Oral medicine, Periodontology and Oral diagnosis, Faculty of dentistry

Study Record Dates

First Submitted

October 1, 2023

First Posted

October 6, 2023

Study Start

February 15, 2024

Primary Completion

March 15, 2024

Study Completion

April 1, 2024

Last Updated

January 31, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share